Department of Neurosurgery, Royal North Shore Hospital, St. Leonards, New South Wales, Australia.
J Neurosurg. 2011 Mar;114(3):756-62. doi: 10.3171/2010.8.JNS091900. Epub 2010 Oct 8.
The aim of this study was to provide disease-specific information about schwannomatosis in its different forms and to present 2 particular cases of malignant schwannomas in the context of familial schwannomatosis (FS).
The authors analyzed patients with pathologically defined schwannomas and identified those with varied forms of schwannomatosis. Each case was retrospectively analyzed for patient sex and age, number of operations and tumors excised, symptoms, location and size of tumors, extent of resection, nerve function pre- and postoperatively, complications, other nonsurgically treated tumors, malignancy, results of brain MR imaging, and follow-up data.
One hundred fifty-eight patients underwent the excision of 216 schwannomas. One hundred forty-two patients presented with solitary schwannomas, 2 had neurofibromatosis Type 2 (NF2), and 14 presented with schwannomatosis. The average follow-up was 52 months. Six individuals had sporadic schwannomatosis, whereas 8 had the familial form of the disease. These 14 patients had an average age of 28.3 years at the time of disease onset (median 27.5 years) and 35.4 years at the time of the first operation (median 37 years) Thirteen of the 14 patients with schwannomatosis experienced pain as the first symptom. Eight (57%) of the 14 patients presented with at least 1 tumor in the spinal canal or attached to the spinal nerve roots. Malignant schwannomas developed in 2 patients from the same family during the follow-up.
Patients suffering from schwannomatosis tend to be younger than those presenting with solitary schwannomas. Therefore, individuals presenting at a young age with multiple schwannomas but not meeting the criteria for NF2 should prompt the physician to suspect schwannomatosis. Patients with schwannomatosis who report pain should be exhaustively examined. The spine is affected in the majority of patients, and MR imaging of the spine should be part of the routine evaluation. Rapid enlargement of schwannomas in the context of FS should raise suspicion of malignant transformation.
本研究旨在提供神经鞘瘤病不同类型的疾病特异性信息,并结合家族性神经鞘瘤病(FS)呈现 2 例恶性神经鞘瘤病例。
作者分析了经病理证实的神经鞘瘤患者,并确定了具有不同形式神经鞘瘤病的患者。对每位患者的性别和年龄、手术次数和切除肿瘤数、症状、肿瘤位置和大小、切除范围、术前和术后神经功能、并发症、其他非手术治疗的肿瘤、恶性程度、脑磁共振成像结果以及随访数据进行回顾性分析。
158 例患者行 216 例神经鞘瘤切除术。142 例患者表现为单发神经鞘瘤,2 例为神经纤维瘤病 2 型(NF2),14 例为神经鞘瘤病。平均随访时间为 52 个月。6 例为散发性神经鞘瘤病,8 例为家族性神经鞘瘤病。这 14 例患者疾病初发时的平均年龄为 28.3 岁(中位数 27.5 岁),首次手术时的平均年龄为 35.4 岁(中位数 37 岁)。14 例神经鞘瘤病患者中有 13 例以疼痛为首发症状。14 例患者中有 8 例(57%)椎管内或神经根附着处至少有 1 个肿瘤。在随访过程中,来自同一家庭的 2 例患者发展为恶性神经鞘瘤。
患有神经鞘瘤病的患者比单发神经鞘瘤患者年轻。因此,年龄较小、有多发性神经鞘瘤但不符合 NF2 标准的患者应引起医生怀疑神经鞘瘤病。有神经鞘瘤病且报告有疼痛的患者应进行彻底检查。大多数患者脊柱受影响,脊柱磁共振成像应作为常规评估的一部分。FS 中神经鞘瘤快速增大应怀疑恶变。